Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Pharmacol Ther. 2010 Oct 31;129(1):21–28. doi: 10.1016/j.pharmthera.2010.09.012

Table.

Major differences between isolation of murine bone marrow-derived and human umbilical cord blood-derived cells.

Murine BM-VSELs Human VSELs
SURFACE MARKERS Sca-1+, CXCR4+, CD133+, CD34+, SSEA-1+, AP+, c-Met+, LIF-R+, CD45−, Lin−, HLA-DR−, MHC I −, CD90−, CD29−, CD105− CXCR4+, CD133+, CD34+, SSEA-4+, AP+, c-Met+, LIF-R+, CD45−, Lin−, HLA-DR−, MHC I −, CD90−, CD29−, CD105−
SIZE    4–5 µm    6–8 µm
FREQUENCY    0.03% of nucleated cells    0.01% of nucleated cells
TISSUES Bone marrow, peripheral blond, brain, muscle, thymus, heart, liver, kidney, testes, spleen, lung, retina, pancreas, fetal liver Bone marrow, umbilical cord blood, peripheral blood
ANTIBODIES USED FOR FACS-BASED ISOLATION anti mouse-Ly-6/E (Sca-1), anti mouse-CD45, anti mouse-lineage: CD45R/B220, Gr-1, TCRαβ, TCRγδ, CD11b, Ter119 anti-human-CD133, anti-human-CD45, anti-human-lineage: CD2,CD3, CD14, CD66b, CD24, CD56, CD16, CD19, CD235a